Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: Clin Drug Investig. 2018 Jun;38(6):491–501. doi: 10.1007/s40261-018-0639-z

Table 2.

Changes in study outcomes

Analysis Studies Comparisons Summary statistics 95% CI Q (p) I2 95% CI
CV mortality for all eligible studies 7 9 0.85 0.68–1.06 23.8 (0.001) 71 39–86
HbA1c 5 6 −0.08 − 0.26 to 0.09 63.6 (0.0001) 92 85.6–95.7

Summary statistics for CV mortality are reported as odds ratio, and for HbA1c are reported as standardized mean difference

CV cardiovascular, CI confidence interval, Q Cochran’s Q, I2 inconsistency, HbA1c glycated hemoglobin